GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$91.42

+1.54 (+1.71%)

(As of 10/4/2024 ET)

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
1

Hold
5

Buy
8

Based on 14 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 5 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$94.23
3.07% Upside

According to the 14 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $94.23. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $74.00. The average price target represents a forecasted upside of 3.07% from the current price of $91.42.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

GEHC Analyst Ratings Over Time

Type	Current Forecast 10/7/23 to 10/6/24	1 Month Ago 9/7/23 to 9/6/24	3 Months Ago 7/9/23 to 7/8/24	1 Year Ago 10/7/22 to 10/7/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$94.23	$95.00	$94.09	$88.44
Forecasted Upside	3.07% Upside	11.65% Upside	23.24% Upside	29.19% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Who are Nvidia’s New Silent Partners? (Ad)

Nvidia knows it can’t stand still as AI continues to grow at an exponential rate. That’s why CEO Jensen Huang consistently has his company ahead of the curve when it comes to artificial intelligence. Nvidia’s added $2 trillion in market cap in 2024.

I call these Nvidia’s “Silent Partners.”

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	S&P 500
Consensus Rating Score	2.57	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	3.07% Upside	10,592.03% Upside	7.03% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Evercore ISI 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$98.00 ➝ $102.00	+10.82%
9/30/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Buy ➝ Buy	$100.00 ➝ $102.00	+10.88%
9/26/2024	UBS Group 4 of 5 stars	G. Doyle Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$84.00 ➝ $74.00	-20.44%
9/18/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$100.00	+15.22%
9/9/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$90.00	+5.77%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$87.00	+10.90%
5/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$94.00 ➝ $86.00	+10.45%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$110.00 ➝ $105.00	+35.45%
4/3/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$88.00 ➝ $103.00	+14.62%
4/1/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $110.00	+22.82%
2/15/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$100.00	+20.24%
2/12/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$74.00 ➝ $86.00	+3.40%
11/30/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$80.00	+18.15%
8/16/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$90.00	+27.59%
5/15/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$97.00	+29.45%
4/19/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$95.00	+13.55%
1/19/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
1/4/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:19 AM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

GE HealthCare Technologies Inc. reported a strong quarterly earnings result, beating analysts' consensus estimates by $0.02 per share, indicating positive financial performance.
Recent insider transactions show CEO Thomas J. Westrick selling shares at an average price of $80.78, potentially signaling confidence in the company's future prospects.
Wall Street analysts have given GE HealthCare Technologies Inc. an average rating of "Moderate Buy" with a target price of $94.58, suggesting potential growth opportunities.
GE HealthCare Technologies Inc. has a market capitalization of $39.55 billion, indicating a sizable presence in the market.
The company's dividend yield of 0.14% and a payout ratio of 3.51% may appeal to income-oriented investors seeking steady returns.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

GE HealthCare Technologies Inc. has a P/E ratio of 25.33, which may suggest the stock is relatively expensive compared to industry peers.
The company's price-to-earnings-growth ratio of 3.26 indicates that investors are paying a premium for future growth potential.
While the company has shown positive revenue growth, the net margin of 8.10% may be lower than some investors' expectations.
GE HealthCare Technologies Inc. has a beta of 1.17, indicating higher volatility compared to the market average, which may not suit all investors.
The stock's 52-week high of $94.50 suggests potential resistance at higher price levels, impacting short-term trading strategies.

GEHC Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $94.23, with a high forecast of $110.00 and a low forecast of $74.00.
: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There is currently 1 sell rating, 5 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.
: According to analysts, GE HealthCare Technologies's stock has a predicted upside of 3.07% based on their 12-month stock forecasts.
: Over the previous 90 days, GE HealthCare Technologies's stock had 2 upgrades and 1 downgrade by analysts.
: GE HealthCare Technologies has been rated by research analysts at BTIG Research, Evercore ISI, JPMorgan Chase & Co., Redburn Atlantic, Stifel Nicolaus, and UBS Group in the past 90 days.
: Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.57 while the average consensus rating score for "medical" companies is 2.79. Learn more on how GEHC compares to other companies.